Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 144


Carbonic anhydrase IX expression in clear cell renal cell carcinoma: an immunohistochemical study comparing 2 antibodies.

Al-Ahmadie HA, Alden D, Qin LX, Olgac S, Fine SW, Gopalan A, Russo P, Motzer RJ, Reuter VE, Tickoo SK.

Am J Surg Pathol. 2008 Mar;32(3):377-82. doi: 10.1097/PAS.0b013e3181570343.


Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.

Bui MH, Seligson D, Han KR, Pantuck AJ, Dorey FJ, Huang Y, Horvath S, Leibovich BC, Chopra S, Liao SY, Stanbridge E, Lerman MI, Palotie A, Figlin RA, Belldegrun AS.

Clin Cancer Res. 2003 Feb;9(2):802-11.


Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma.

Leibovich BC, Sheinin Y, Lohse CM, Thompson RH, Cheville JC, Zavada J, Kwon ED.

J Clin Oncol. 2007 Oct 20;25(30):4757-64.


Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.

Stillebroer AB, Mulders PF, Boerman OC, Oyen WJ, Oosterwijk E.

Eur Urol. 2010 Jul;58(1):75-83. doi: 10.1016/j.eururo.2010.03.015. Epub 2010 Mar 23. Review.


Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials.

Zhou GX, Ireland J, Rayman P, Finke J, Zhou M.

Urology. 2010 Feb;75(2):257-61. doi: 10.1016/j.urology.2009.09.052. Epub 2009 Dec 5.


Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma.

Bui MH, Visapaa H, Seligson D, Kim H, Han KR, Huang Y, Horvath S, Stanbridge EJ, Palotie A, Figlin RA, Belldegrun AS.

J Urol. 2004 Jun;171(6 Pt 1):2461-6.


Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker.

Klatte T, Seligson DB, Rao JY, Yu H, de Martino M, Kawaoka K, Wong SG, Belldegrun AS, Pantuck AJ.

Cancer. 2009 Apr 1;115(7):1448-58. doi: 10.1002/cncr.24163.


Carbonic anhydrase IX expression in clear cell renal cell carcinomas negatively correlates with the proportion of the granular cell component.

Skapa P, Hyrsl L, Zavada J, Soukup J, Zamecnik J.

J Clin Oncol. 2008 Aug 1;26(22):3809-11; author reply 3811-2. doi: 10.1200/JCO.2008.17.6511. No abstract available.


Carbonic anhydrase IX expression in clear cell renal cell carcinoma and normal tissues: experiences from (radio) immunotherapy.

Brouwers AH, Mulders PF, Oyen WJ.

J Clin Oncol. 2008 Aug 1;26(22):3808-9; author reply 3811-2. doi: 10.1200/JCO.2008.17.6073. No abstract available.


Carbonic anhydrase IX is expressed in mesothelioma and metastatic clear cell renal cell carcinoma of the lung.

Ramsey ML, Yuh BJ, Johnson MT, Yeldandi AV, Zynger DL.

Virchows Arch. 2012 Jan;460(1):89-93. doi: 10.1007/s00428-011-1178-7. Epub 2011 Dec 6.


Carbonic Anhydrase IX is not a predictor of outcomes in non-metastatic clear cell renal cell carcinoma - a digital analysis of tissue microarray.

Zerati M, Leite KR, Pontes-Junior J, Segre CC, Reis ST, Srougi M, Dall'Oglio MF.

Int Braz J Urol. 2013 Jul-Aug;39(4):484-92. doi: 10.1590/S1677-5538.IBJU.2013.04.05.


Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma.

Phuoc NB, Ehara H, Gotoh T, Nakano M, Kamei S, Deguchi T, Hirose Y.

Oncol Rep. 2008 Sep;20(3):525-30.


Expression of carbonic anhydrase IX in genitourinary and adrenal tumours.

Donato DP, Johnson MT, Yang XJ, Zynger DL.

Histopathology. 2011 Dec;59(6):1229-39. doi: 10.1111/j.1365-2559.2011.04074.x.


Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma.

Tickoo SK, Alden D, Olgac S, Fine SW, Russo P, Kondagunta GV, Motzer RJ, Reuter VE.

J Urol. 2007 Apr;177(4):1258-63.


Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade.

Genega EM, Ghebremichael M, Najarian R, Fu Y, Wang Y, Argani P, Grisanzio C, Signoretti S.

Am J Clin Pathol. 2010 Dec;134(6):873-9. doi: 10.1309/AJCPPPR57HNJMSLZ.


Antibody-specific detection of CAIX in breast and prostate cancers.

Li Y, Wang H, Oosterwijk E, Selman Y, Mira JC, Medrano T, Shiverick KT, Frost SC.

Biochem Biophys Res Commun. 2009 Aug 28;386(3):488-92. doi: 10.1016/j.bbrc.2009.06.064. Epub 2009 Jun 16.


Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.

Klatte T, Seligson DB, Riggs SB, Leppert JT, Berkman MK, Kleid MD, Yu H, Kabbinavar FF, Pantuck AJ, Belldegrun AS.

Clin Cancer Res. 2007 Dec 15;13(24):7388-93.


Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer.

Choschzick M, Oosterwijk E, Müller V, Woelber L, Simon R, Moch H, Tennstedt P.

Virchows Arch. 2011 Aug;459(2):193-200. doi: 10.1007/s00428-011-1105-y. Epub 2011 Jun 21.


VHL mutations and dysregulation of pVHL- and PTEN-controlled pathways in multilocular cystic renal cell carcinoma.

von Teichman A, Compérat E, Behnke S, Storz M, Moch H, Schraml P.

Mod Pathol. 2011 Apr;24(4):571-8. doi: 10.1038/modpathol.2010.222. Epub 2010 Dec 10.


Prognostic value of carbonic anhydrase IX immunohistochemical expression in renal cell carcinoma: a meta-analysis of the literature.

Zhao Z, Liao G, Li Y, Zhou S, Zou H, Fernando S.

PLoS One. 2014 Nov 26;9(11):e114096. doi: 10.1371/journal.pone.0114096. eCollection 2014.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk